Fig. 1From: Preclinical comparison of [177Lu]Lu-rhPSMA-10.1 and [177Lu]Lu-rhPSMA-10.2 for endoradiotherapy of prostate cancer: biodistribution and dosimetry studiesChemical structure of the Lu-rhPSMA-10 isomers, differing in the stereoconfiguration of diaminopropionic acid (Dap) branching unit. D-Dap: rhPSMA-10.1 and L-Dap: rhPSMA-10.2. The PSMA inhibitor displays two moieties for radiolabeling: A silicon–fluoride acceptor (SiFA, colored in green), allowing 18F-labeling for PET, and a chelator (colored in orange) for complexation of radiometalsBack to article page